The PennZone

  • Home
  • Books
  • Entertainment
  • Marketing
  • Non-profit
  • Music
  • Education
  • Legal
  • Business

Webinar Announcement: Navigating the New Investment Adviser AML Mandate: What Steps Should Investment Advisers Be Taking Now?
The PennZone/10290960

Trending...
  • Allstream Energy Partners Nominated in Multiple Categories for Fast Company's Best Workplaces for Innovators
  • Congressman Chuck Edwards (NC-11) Presents ReadyCommunities Partnership 2026 National Service Award to Local Businessman / US Air Force Veteran
  • Garage door installation or repair in Minnesota? Which makes more sense for your family?
Navigating the New Investment Adviser AML Mandate K2 Integrity
NEW YORK - PennZone -- K2 Integrity, the leading investigations and financial crimes advisory firm, is pleased to announce an upcoming webinar addressing the implementation of the new Investment Adviser Anti-Money Laundering (AML) Final Rule. This significant development mandates compliance by 1 January 2026, requiring investment advisers to adopt policies, procedures, and controls consistent with Bank Secrecy Act (BSA) requirements.

The webinar will provide investment advisers and other financial professionals with critical insights into the complexities of the rule, the inherent risks, and the necessary steps to achieve compliance.

"Our goal is to equip investment advisers with the knowledge and tools to navigate these changes effectively, ensuring they meet the new compliance requirements without disrupting operations," said Sarah Runge, executive managing director at K2 Integrity.

More on The PennZone
  • Put Your Herd on Your Phone: Kiko Nation Makes Livestock Management Simple
  • Future Intelligence Think Tank Surpasses 1,000 Members Exploring Human and Artificial Intelligence
  • Gary Bernstein Expands Media Leadership Role With Senior Strategic Advisor Appointment To Blacksun Private Equity
  • Headline: House of Nova Paints Every Face in Gold at New York Fashion Week
  • Can Government Operate Better Through Innovation?

The expert panel will discuss:
  • The broader complexities of the IA BSA/AML Rule beyond the KYC requirements
  • Identifying key inherent AML risks
  • Establishing an appropriate timeline for implementation
  • What to expect during the examination process
  • The consequences of noncompliance

Panelists:
  • Justina Rousseau, Senior Managing Director, K2 Integrity
  • Aseel M. Rabie, Counsel, Debevoise & Plimpton LLP
  • Moderator: Sarah Runge, Executive Managing Director, K2 Integrity

Registration for this webinar is now open. Interested participants can secure their place here.

About K2 Integrity
K2 Integrity is a global leader in risk management, compliance, investigations, and monitoring, combining the expertise of industry pioneers with interdisciplinary teams and advanced technology to protect our clients' operations, reputation, and financial security.

More on The PennZone
  • Michael H. Kaplan Advocates for Seriously Injured Colorado Workers Who Need In-Home Care
  • Her Song Lives On: Remembering Mrs. Darlene Davis Porter
  • Infinity Infusion Solutions Named Finalist for D Magazine's D CEO 2026 Excellence in Healthcare Awards
  • Pittsburgh Creators Launch Clever New Children's Book, "The Sock Sleuth!"
  • Canadian Tint Expo 2027: Why Every Window Tinter Should Compete in Niagara Falls on April 3rd & 4th

K2 Integrity is dedicated to ensuring, strengthening, and validating financial and commercial integrity and security. We understand that critical moments define an organization's success. We strive to build financial and institutional integrity, reduce risk, and uncover truth. Our commitment to superior intelligence, expert analysis, and insightful solutions helps our clients navigate complexity and achieve better outcomes.

To learn more about how K2 Integrity is revolutionizing the management of risk, visit www.k2integrity.com.

Stay Connected:

Follow K2 Integrity on LinkedIn and Twitter.

Source: K2 Integrity

Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on The PennZone
  • Scoop Social Co. Brings Its Signature Mobile Dessert Experience to Houston This October
  • The Social Capital Revolution Comes to Phoenix!
  • Lawsuit Alleges American Deli Food Caused Severe Illness, Acute Kidney Failure, And Eight-day Hospitalization
  • FBI/DoW plot uncovered to hurt Trump/Vance through encouraged "widespread" cybersecurity breaches and racketeering theft of $80m in USDA payments
  • Bettingbladet releases H1 2026 report on the Swedish online gambling market
  • Garage door installation or repair in Minnesota? Which makes more sense for your family?
  • SMACK Fight Week Takes Over Philadelphia
  • Super Rooter Expands to 190 Plumbing, Sewer, and Drain Service Locations Across the United States
  • European Patent for ALS Program Expands the Story: HOPE Deploys Robotic TMS & FDA Commercialization Path Advances: NRx Pharmaceuticals: NAS DAQ: NRXP
  • VICTURY Sports Announces Formation of Youth Sports League Built on the Official, Patented, and Award-Winning Keepy Uppy® Ball
  • Spearmint Publishes Full Design of Its Mining Pool Before Building It, Including Legal Drafts
  • Congressman Chuck Edwards (NC-11) Presents ReadyCommunities Partnership 2026 National Service Award to Local Businessman / US Air Force Veteran
  • Cress Creeks Farm Opens Fall Corn Maze and Baby Lamb Hayride Experience in Ellijay, Georgia
  • Brewtay Coffee Introduces Specialty Instant Line Designed for High-Velocity Commuters and Travelers
  • Allstream Energy Partners Nominated in Multiple Categories for Fast Company's Best Workplaces for Innovators
  • Ten Ten Ten Awards Provisional Certification to Cara AI for Home-Based Health Assessments
  • IDI Consulting Partners with the American Heart Association to Advance Heart Health Awareness
  • Kerri Lawless Introduces New Home-Selling Option for Local Homeowners
  • Bethany Nikitenko Appointed to Philadelphia Trial Lawyers Association Diversity Committee
  • FDA-Cleared Zeta TMS Robotic System Moves Toward Deployment as FDA, DARPA and Commercial Catalysts Converge: NRx Pharmaceuticals (N A S D A Q: NRXP)

Popular on PennZone

  • Benny Turner Revisits Freddie King's Legacy for 50th Anniversary of His Passing - 221
  • Easwe Lightweight Electric Wheelchair Collection with Travel-Focused Mobility Solutions - 196
  • Church Tradition Takes an Unexpected Turn at the Ford Community & Performing Arts Center - 189
  • Master Of Science, Juggernaut Of The Screen: Landon Brittain Emerges As Hollywood's Most Unlikely Leading Man - 182
  • 3ptechies Partners with Coolmuster to Give Away Data Recovery Software Licenses - 174
  • Black Dog Venture Partners and VC Fast Pitch to Host "San Francisco Investors and Innovators" Networking Event - 154
  • FindCostSeg Launches Nationwide Directory for Cost Segregation Providers - 147
  • GitKraken Names Jim Shaw CEO as Software Teams Move From AI Adoption to Multi-Agent Orchestration - 144
  • INAD Warriors' 4th Annual "Dancing with the INAD Stars" Gala - 141
  • Michael Fischer, President and CEO of Client 1st Financial, Named to LVB 300 - 120

Similar on PennZone

  • Matt Zavala of Zavala Law, PC Selected to the 2027 Super Lawyers List
  • Ragin' Cajun Announces New Cheeseburger Seasoning on National Cheeseburger Day
  • Warrant Activity, AVERSA™ Progress and a Potentially Transformative Fall Take Center Stage: Nutriband Inc. (N A S D A Q: NTRB)
  • Put Your Herd on Your Phone: Kiko Nation Makes Livestock Management Simple
  • Future Intelligence Think Tank Surpasses 1,000 Members Exploring Human and Artificial Intelligence
  • Gary Bernstein Expands Media Leadership Role With Senior Strategic Advisor Appointment To Blacksun Private Equity
  • Can Government Operate Better Through Innovation?
  • Michael H. Kaplan Advocates for Seriously Injured Colorado Workers Who Need In-Home Care
  • Infinity Infusion Solutions Named Finalist for D Magazine's D CEO 2026 Excellence in Healthcare Awards
  • Building a Diversified Healthcare Platform as Exosome Science, Telehealth, Diagnostics & Strategic Acquisitions Converge: NexTel Medical (OTCID: MAJI)
Copyright © The PennZone | Theme: OMag by LilyTurf Themes
  • Contribute
  • Privacy Policy
  • Terms of Service
  • Contact Us